CSF2 and acute myeloid leukemia: The mechanism of disease probably involves the selective impairment of ROS production by alveolar macrophages in vivo, as suggested by our analysis of GM-CSF-matured MDMs and AML cells in vitro and lung macrophages ex vivo2,13.